利潔時集團(Reckitt Benckier Group)對摩根大通的評級為「增持」。

JPMorgan Chase & Co. reissued their overweight rating on shares of Reckitt Benckiser Group (LON:RKT – Get Rating) in a research report sent to investors on Wednesday morning, Marketbeat Ratings reports.

RKT has been the subject of several other reports. Barclays reaffirmed an overweight rating and set a GBX 9,300 ($112.62) price objective on shares of Reckitt Benckiser Group in a research report on Friday, May 20th. Royal Bank of Canada reaffirmed an outperform rating and set a GBX 7,000 ($84.77) price objective on shares of Reckitt Benckiser Group in a research report on Wednesday, June 29th. Morgan Stanley reaffirmed an overweight rating on shares of Reckitt Benckiser Group in a research report on Wednesday, May 11th. Deutsche Bank Aktiengesellschaft reaffirmed a buy rating and set a GBX 7,200 ($87.19) price objective on shares of Reckitt Benckiser Group in a research report on Friday, June 24th. Finally, Berenberg Bank increased their price target on Reckitt Benckiser Group from GBX 7,460 ($90.34) to GBX 7,700 ($93.24) and gave the company a buy rating in a research report on Friday, April 29th. Seven equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has an average rating of Buy and a consensus price target of GBX 7,685.71 ($93.07).

Get

Reckitt Benckiser Group

alerts:

LON:RKT opened at GBX 6,364 ($77.06) on Wednesday. Reckitt Benckiser Group has a 1 year low of GBX 4,905.16 ($59.40) and a 1 year high of GBX 6,600 ($79.92). The company has a current ratio of 0.62, a quick ratio of 0.40 and a debt-to-equity ratio of 129.26. The stock has a market cap of £45.53 billion and a price-to-earnings ratio of -1,413.78. The stock has a 50-day moving average price of GBX 6,205.46 and a two-hundred day moving average price of GBX 6,108.35.

In other Reckitt Benckiser Group news, insider Laxman Narasimhan sold 7,713 shares of the company's stock in a transaction that occurred on Friday, May 20th. The stock was sold at an average price of GBX 6,214 ($75.25), for a total value of £479,285.82 ($580,389.71).

About Reckitt Benckiser Group (Get Rating)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Featured Articles

• 3 Growth Stocks Trading at Value P/E's
• Capri Holdings Stock Looks Attractive For a Premium Retailer
• The Sell-Off In Kornit Digital May Set Up A 2nd Half Opportunity
• Phreesia Stock is a Healthcare IT Play
• Recession Resistant Grocery Outlet Holding Corp Quietly Sets New High

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.